Clinical trial
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
- Lead sponsor
- Leiden University Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 19, 2022
- Completion date
- August 31, 2023
- Enrollment
- 90 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel diseases, iron deficiency anemia, iron-deficiency